Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study

BACKGROUND: OnabotulinumtoxinA is approved for the prevention of headache in those with chronic migraine (CM); however, more clinical data on the risk-benefit profile for treatment beyond one year is desirable. METHODS: The Chronic Migraine OnabotulinuMtoxinA Prolonged Efficacy open Label (COMPEL) S...

Descripción completa

Detalles Bibliográficos
Autores principales: Blumenfeld, Andrew M., Stark, Richard J., Freeman, Marshall C., Orejudos, Amelia, Manack Adams, Aubrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799088/
https://www.ncbi.nlm.nih.gov/pubmed/29404713
http://dx.doi.org/10.1186/s10194-018-0840-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5799088/
https://www.ncbi.nlm.nih.gov/pubmed/29404713
http://dx.doi.org/10.1186/s10194-018-0840-8

Ejemplares similares